BRIEF published on 10/13/2026 at 18:15, 17 days 2 hours ago Medincell obtient un financement non dilutif de 41,8 millions d'euros Financement Non Dilutif Produits Biopharmaceutiques Banque Européenne D'investissement Medincell Échéance De La Dette
BRIEF published on 10/13/2026 at 18:15, 17 days 2 hours ago Medincell Secures €41.8 Million in Non-Dilutive Financing Debt Maturity Non-dilutive Financing Biopharmaceuticals European Investment Bank Medincell
BRIEF published on 10/13/2026 at 18:15, 17 days 2 hours ago Medincell strengthens its financing with a new non-dilutive loan Treasury Funding Biopharmaceutical Medincell Non-dilutable
BRIEF published on 10/13/2026 at 18:15, 17 days 2 hours ago Medincell renforce son financement avec un nouveau prêt non dilutif Financement Biopharmaceutique Trésorerie Medincell Non Dilutif
PRESS RELEASE published on 10/13/2026 at 18:10, 17 days 2 hours ago Inside Information / Other news releases Medincell secures €13.8 million non-dilutive financing, totaling €41.8 million. Debt maturity extended through 2031. No equity instruments used for financing Debt Maturity Non-dilutive Financing Bpifrance Medincell European Commercial Banks
PRESS RELEASE published on 10/13/2026 at 18:10, 17 days 2 hours ago Informations privilégiées / Autres communiqués Medincell obtient un financement non dilutif de 13,8 M€, portant le total à 41,8 M€ depuis juillet 2026. Aucune dilution pour les actionnaires. Détails sur la structure financière et les traitements innovants Biopharmaceutique Structure Financière Financement Non Dilutif Medincell Traitements Innovants
BRIEF published on 10/09/2026 at 15:03, 21 days 5 hours ago Reprise de la cotation des actions Medincell sur Euronext Paris FDA Euronext Medincell Teva Olanzapine LAI
BRIEF published on 10/09/2026 at 15:03, 21 days 5 hours ago Medincell Resumes Trading on Euronext Paris Euronext Paris FDA Approval Trading Resumption Medincell BEPO Technology
BRIEF published on 10/09/2026 at 15:03, 21 days 5 hours ago Medincell reprend sa cotation sur Euronext Paris Euronext Paris Approbation De La FDA Medincell Reprise Des Échanges Technologie BEPO
BRIEF published on 10/09/2026 at 15:03, 21 days 5 hours ago Medincell shares resume trading on Euronext Paris FDA Euronext Medincell Teva Olanzapine LAI
Published on 10/30/2026 at 19:00, 1 hour 25 minutes ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 4 hours 55 minutes ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/30/2026 at 12:20, 8 hours 5 minutes ago Silver X Files NI 43-101 Technical Report for the Updated Nueva Recuperada Mineral Resource: 10.4 Mt Measured and Indicated at 202 g/t AgEq (67.3 Moz AgEq) and 21.6 Mt Inferred at 260 g/t AgEq (184.3 Moz AgEq)
Published on 10/30/2026 at 12:00, 8 hours 25 minutes ago Aztec Minerals Strengthens Technical Management Team
Published on 10/29/2026 at 22:01, 22 hours 24 minutes ago Pinetree Capital Announces Unaudited Financial Results for the Period Ended September 30, 2026
Published on 10/30/2026 at 18:38, 1 hour 47 minutes ago EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report
Published on 10/30/2026 at 18:35, 1 hour 49 minutes ago EQS-Adhoc: hep global GmbH expects to conclude refinancing negotiations only in fiscal year 2027
Published on 10/30/2026 at 18:05, 2 hours 20 minutes ago lePERMISLIBRE divise par trois sa perte d’exploitation au premier semestre 2026
Published on 10/30/2026 at 18:00, 2 hours 25 minutes ago 2026 half-year earnings & third quarter revenue
Published on 10/30/2026 at 18:00, 2 hours 25 minutes ago Laboratoires Euromedis - Communiqué résultat semestriel 2026
Published on 10/30/2026 at 18:00, 2 hours 25 minutes ago Résultats du 1er semestre 2026 et chiffre d'affaires du 3ème trimestre 2026
Published on 10/30/2026 at 18:00, 2 hours 25 minutes ago LABORATOIRES EUROMEDIS - RAPPORT FINANCIER SEMESTRIEL 2026
Published on 10/30/2026 at 17:45, 2 hours 40 minutes ago Déclaration au titre de l’article 223-16 du Règlement Général de l’Autorité des Marchés Financiers
